Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2004
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
S Akerman, H Kaube, P J Goadsby
Journal of Neurology
|
August 27, 1999
Antimigraine drugs
H C Diener, H Kaube, V Limmroth
Der Anaesthesist
|
January 13, 2000
[Migraine. Symptoms, diagnosis and drug therapy]
H C Diener, H Kaube, V Limmroth
British Journal of Pharmacology
|
October 10, 2003
Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation
S Akerman, H Kaube, P J Goadsby
Drugs
|
November 26, 1998
A practical guide to the management and prevention of migraine
H C Diener, H Kaube, V Limmroth
Der Internist
|
May 8, 2000
[Migraine: clinical aspects, diagnosis and pharmacotherapy]
H C Diener, H Kaube, V Limmroth
British Journal of Pharmacology
|
July 28, 2004
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors
S Akerman, H Kaube, P J Goadsby
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 19, 2005
Occipital activation in glyceryl trinitrate induced migraine with visual aura
S Afridi, H Kaube, P J Goadsby
Brain : a Journal of Neurology
|
October 1, 1996
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism
K L Hoskin, H Kaube, P J Goadsby
Pain
|
August 4, 2004
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
K S Afridi, H Kaube, J P Goadsby
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
The Journal of Pharmacology and Experimental Therapeutics
|
January 14, 2004
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
S Akerman, H Kaube, P J Goadsby
Journal of Neurology
|
August 27, 1999
Antimigraine drugs
H C Diener, H Kaube, V Limmroth
Der Anaesthesist
|
January 13, 2000
[Migraine. Symptoms, diagnosis and drug therapy]
H C Diener, H Kaube, V Limmroth
British Journal of Pharmacology
|
October 10, 2003
Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation
S Akerman, H Kaube, P J Goadsby
Drugs
|
November 26, 1998
A practical guide to the management and prevention of migraine
H C Diener, H Kaube, V Limmroth
Der Internist
|
May 8, 2000
[Migraine: clinical aspects, diagnosis and pharmacotherapy]
H C Diener, H Kaube, V Limmroth
British Journal of Pharmacology
|
July 28, 2004
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors
S Akerman, H Kaube, P J Goadsby
Journal of Neurology, Neurosurgery, and Psychiatry
|
July 19, 2005
Occipital activation in glyceryl trinitrate induced migraine with visual aura
S Afridi, H Kaube, P J Goadsby
Brain : a Journal of Neurology
|
October 1, 1996
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism
K L Hoskin, H Kaube, P J Goadsby
Pain
|
August 4, 2004
Glyceryl trinitrate triggers premonitory symptoms in migraineurs
K S Afridi, H Kaube, J P Goadsby
Page
of 7